Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Basilea Pharmaceutica AG
DescriptionSiderophore sulfactam antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infection; Treat multidrug-resistant Gram-negative bacterial infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today